Edwards Lifesciences · Health Care
EW
$85.73
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease.爱德华生命科学公司是一家美国医疗技术企业，总部位于加利福尼亚州尔湾，专注于用于治疗结构性心脏病的组织心脏瓣膜和经导管技术。
Quality compounder优质复利股
Large cap大盘
$50B
Engine stance引擎立场2026-07-20
Constructive — building a base建设性 — 正在筑底
The bottoming setup is not yet confirmed (price still below the 10-day average) and the 3-day/weekly momentum has crosse筑底形态尚未确认（价格仍位于 10 日均线下方），且3 日/周线动量已向下交叉——动量在形态完成前已开始衰竭。等待价格收复 10 日均线且动量趋于稳定后再考虑建仓。
Key Statistics关键统计
Price价格
$85.73
9.9% below 52-week high低于52周高点 9.9%
Market Cap市值
$50B
Normal volume正常成交量
P/E Ratio市盈率
46.4x
28.9x sector median
Beta贝塔
0.58
Moves about 0.6x the market波动幅度约为市场的 0.6 倍
RSI (14)RSI（14）
40
Depressed偏低
Next Earnings下次财报
2026-07-23 (4d)
Volatility Rank波动率分位
67th pctile
hist. vol. percentile历史波动率分位数
Short Interest空头兴趣
2.0% of float
Performance价格表现
| Period周期 | EW | S&P 500 | vs Index对比指数 |
|---|---|---|---|
| 1 Week近1周 | -7.0% | -1.5% | Lagged the index by 5.5 points落后指数 5.5 个百分点 |
| 1 Month近1月 | -1.1% | +0.6% | Lagged the index by 1.7 points落后指数 1.7 个百分点 |
| 3 Months近3月 | +5.9% | +4.7% | Beat the index by 1.2 points跑赢指数 1.2 个百分点 |
| 6 Months近6月 | +1.6% | +7.8% | Lagged the index by 6.2 points落后指数 6.2 个百分点 |
| Year to date年初至今 | +0.5% | +9.1% | Lagged the index by 8.6 points落后指数 8.6 个百分点 |
| 1 Year近1年 | +12.5% | +19.4% | Lagged the index by 6.9 points落后指数 6.9 个百分点 |
Technicals技术面
RSI (14)RSI（14）
40
Depressed偏低
vs 50-day相对50日均线
-1.4% vs 50-day avg
vs 200-day相对200日均线
+3.0% vs 200-day avg
Volatility rank波动率分位
67th percentile 分位
Engine reference levels — not advice引擎参考水平 — 非投资建议
Buy zone买入区间
$83.91
Don't chase above不追高于
$85.73
Stop止损
$85.11
Extended — wait for a pullback过度拉伸 — 等待回撤
Earnings财务业绩
4
days until next report天后公布财报
2026-07-23
Estimates being raised — 3 analysts预期上调 — 3 位分析师
Post-earnings drift: -4.9% (20d)财报后漂移：-4.9%（20日）
Earnings call transcripts — coming soon财报电话会议记录 — 即将上线
Valuation估值
| Multiple指标 | EW | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率（历史） | 46.37x | 28.92 | 21% |
| P/B市净率 | 4.82x | 3.52 | 32% |
| P/S市销率 | 8.20x | 3.02 | 16% |
| Earnings yield盈利收益率 | 2.16% | 2.72 | 42% |
| FCF yield自由现金流收益率 | 2.68% | 3.94 | 31% |
| Shareholder yield股东收益率 | 1.79% | 1.89 | 47% |
| EV/EBITDA企业价值/EBITDA | 33.39x | 18.21 | 17% |
| P/FCF市值/自由现金流 | 37.29x | 22.42 | 20% |
Analyst price targets — coming soon分析师目标价 — 即将上线
Financials财务数据
Revenue营业收入
5yr CAGR5年复合增速: 6.7%
Earnings Per Share每股收益
5yr CAGR5年复合增速: 7.1%
Free Cash Flow自由现金流
Margins利润率
10.4%Return on Equity股本回报率
7.8%Return on Assets资产回报率
Leverage杠杆
| Net debt / EBITDA净债务/EBITDA | -1.65 |
| Current ratio流动比率 | 3.72 |
Capital Allocation资本配置
| Buybacks (TTM)回购（TTM） | $893.4M |
| Stock-based comp股权薪酬 | $158.1M |
| Share count change (1y)股数变化（1年） | -1.3% |
Piotroski皮奥特罗斯基 6/9
Altman Z阿尔特曼Z: safe (11.5)
Clean稳健
Snapshot Gauges综合指标
Valuation vs Sector估值相对行业
Expensive vs sector相对行业偏贵
Cheaper than 23% of its sector on blended multiples综合估值倍数低于行业内 23% 的公司
Beta市场敏感度
0.58×
0.21×3×
Moves about 0.6× the market波动幅度约为市场的 0.6 倍
Financial Health财务健康
6/9
Altman阿尔特曼: safe
Adequate financial health财务健康状况一般
Dividend分红
—
Does not pay a dividend不派发股息
Why Is It Moving为何波动
Sector / Theme行业/主题
Health Care (Equal-Weight) theme — #6 of 46 themes「医疗保健（等权）」主题 — 46 个主题中第 6 位
Macro宏观
Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓
Insider cluster activity内部人集中交易
Technical技术面
EW daily MACD crossed downEW 日线MACD下穿
Options Positioning期权持仓
Market makers are net long gamma — price pinned near current level做市商净持有正伽玛，价格倾向于在当前水平附近震荡
Expected daily move预期日波动
±2.09%
Expected weekly move预期周波动
±4.67%
Call wall看涨密集区
$92
Put wall看跌密集区
$80
Gamma flip伽玛翻转
$80
25d risk reversal25d风险逆转
-3.1%
Skew: 偏斜：fear
Ownership & Smart Money持仓与聪明钱
Insider activity内部人员活动: -$13.3M net (0 buyers, 7 sellers)-$13.3M 净值（0 买家，7 卖家）
Concentrated ownership集中持仓
| Fund基金 | Grade评级 | Activity动作 | % of portfolio组合占比 | As of截至 |
|---|---|---|---|---|
| Viking Global (Halvorsen) | B | New position新建仓 | 0.2% | 2026-03-31 |
Signal History信号历史
TURN SIGNALED
BOTTOMING
Jul 13, 2026
EW daily MACD crossed downEW 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $91.79.日线MACD柱状图转负 — 快速且嘈杂，仅作背景。$91.79。
Jul 6, 2026
UPTREND → NEARING A HIGH上涨趋势 → 接近高点
TAKE PROFITS止盈
Jul 2, 2026
BUY ZONE → UPTREND买入区 → 上涨趋势
HOLD持有
Jul 2, 2026
EW took relative-strength leadershipEW 取得相对强弱领先
Relative strength vs SPY crossed above the 90th percentile of the last 90 days — leadership tends to persist. $94.37.相对标普500的强弱上穿近90日的第90百分位 — 领先往往延续。$94.37。
Jul 2, 2026
EW RSI reached overboughtEW RSI进入超买
RSI(14) crossed above 70 — stretched to the upside; context, not a timing trigger alone. $94.37.RSI(14)上穿70 — 上行过度；仅作背景，单独不构成择时。$94.37。
Jul 1, 2026
EW made a new 52-week highEW 创52周新高
Price reached a fresh 52-week high — a momentum / trend extreme the whole market watches. $91.99.价格创出52周新高 — 全市场关注的动量/趋势极值。$91.99。
Jun 24, 2026
NEARING A HIGH → BUY ZONE接近高点 → 买入区
BUY买入
Jun 24, 2026
EW made a new 52-week highEW 创52周新高
Price reached a fresh 52-week high — a momentum / trend extreme the whole market watches. $89.66.价格创出52周新高 — 全市场关注的动量/趋势极值。$89.66。
Jun 24, 2026
EW daily MACD crossed upEW 日线MACD上穿
The daily MACD histogram turned positive — fast and noisy, context rather than a standalone trigger. $89.66.日线MACD柱状图转正 — 快速且嘈杂，仅作背景。$89.66。
Jun 23, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Jun 22, 2026
UPTREND → BOTTOMING上涨趋势 → 筑底中
BUY SETUP买入预备
Showing last 15 of显示最近15条，共 110 signals条信号
Factor Profile因子特征
Composite factor score综合因子得分: 0.12
Value价值
-0.7
Profitability盈利能力
+0.2
Quality质量
+0.7
Investment资本投入
+0.2
Shareholder payout股东回报
-0.6
Low volatility低波动
+0.9
Low market beta低市场敏感度
+0.3
Earnings quality盈利质量
-0.1
Short interest空头兴趣
+1.0
Company Profile公司档案
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease.爱德华生命科学公司是一家美国医疗技术企业，总部位于加利福尼亚州尔湾，专注于用于治疗结构性心脏病的组织心脏瓣膜和经导管技术。
Watch items — what could change the thesis关注项 — 可能改变论点的因素
- Margin compression despite revenue growth
Get the full picture获取完整视图
Nightly signals, options flow, and factor analysis across all S&P 500 names.每日更新的信号、期权资金流向和因子分析，覆盖所有标普500成分股。